A comparison of Huntington disease and Huntington disease-like 2 neuropathology

被引:65
作者
Rudnicki, Dobrila D. [1 ]
Pletnikova, Olga [2 ]
Vonsattel, Jean-Paul G. [3 ]
Ross, Christopher A. [4 ,5 ]
Margolis, Russell L. [4 ]
机构
[1] Johns Hopkins Univ, Sch Med, Div Neurobiol, Dept Psychiat, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Div Neurobiol, Dept Pathol, Baltimore, MD USA
[3] Columbia Univ, Med Ctr, Columbia Presbyterian Med Ctr, New York, NY USA
[4] Johns Hopkins Univ, Sch Med, Dept Neurol,Program Cellular & Mol Med, Div Neurobiol,Dept Psychiat, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Sch Med, Dept Neursci,Program Cellular & Mol Med, Div Neurobiol,Dept Psychiat, Baltimore, MD 21205 USA
关键词
myotonic dystrophy; neurodegeneration; trinucleotide;
D O I
10.1097/NEN.0b013e31816b4aee
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Huntington disease-like 2 (HDL2) is an autosomal dominant disorder characterized by adult-onset, progressive motor abnormalities, psychiatric disturbances, and dementia ending in premature death. Clinically, it most closely resembles Huntington disease (HD), although a subset of affected individuals have parkinsonian features. Here, we systematically compare 5 HDL2 and 5 HD brains with the hypothesis that, reflecting the clinical presentation, the neuropathology of the 2 diseases would be similar. Gross and microscopic examination revealed prominent striatal neuron loss and astrocytic gliosis in a dorsal to ventral gradient in each disorder and cortical atrophy. Nuclear protein aggregates were as common in HDL2 as in HID, and the ultrastructural features of HDL2 and HD aggregates were similar. Electron microscopy also revealed degenerating neurons, some with evidence of autophagy, in both HDL2 and HD. Small ribonuclear foci, previously associated with potentially neurotoxic RNA transcripts in HDL2, rarely colocalized with protein aggregates in HDL2 brain, although the protein aggregates were stained by anti-TATA-box binding protein antibodies. Overall, the neuropathologic features of HDL2 and HD are very similar but not identical, suggesting that the pathogenetic mechanisms of the 2 diseases may partially overlap.
引用
收藏
页码:366 / 374
页数:9
相关论文
共 50 条
  • [31] THERAPEUTIC TARGETS FOR HUNTINGTON'S DISEASE
    Sorbera, L. A.
    Dulsat, C.
    Rosa, E.
    DRUGS OF THE FUTURE, 2012, 37 (06) : 437 - 443
  • [32] Transgenic models of Huntington's disease
    Sathasivam, K
    Hobbs, C
    Mangiarini, L
    Mahal, A
    Turmaine, M
    Doherty, P
    Davies, SW
    Bates, GP
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1386) : 963 - 969
  • [33] Huntington's disease: A bimolecular vision
    Leite, JF
    REVISTA DE NEUROLOGIA, 2001, 32 (08) : 762 - 767
  • [34] Molecular Biology of Huntington's Disease
    Ersoy, Nagehan
    Basak, A. Nazli
    TURKISH JOURNAL OF NEUROLOGY, 2005, 11 (01) : 27 - 44
  • [35] Anosognosia and Memory Encoding in Huntington Disease
    Considine, Ciaran Michael
    Hughes, Shelby
    Gibson, Jessie Sellers
    Isaacs, David
    McDonell, Katherine
    Darby, R. Ryan
    Claassen, Daniel
    COGNITIVE AND BEHAVIORAL NEUROLOGY, 2022, 35 (01) : 40 - 48
  • [36] DNA Methylation in Huntington's Disease
    Zsindely, Nora
    Siagi, Fruzsina
    Bodai, Laszlo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [37] Huntington's disease, calcium, and mitochondria
    Giacomello, Marta
    Hudec, Roman
    Lopreiato, Raffaele
    BIOFACTORS, 2011, 37 (03) : 206 - 218
  • [38] Evidence for a recruitment and sequestration mechanism in Huntington's disease
    Preisinger, E
    Jordan, BM
    Kazantsev, A
    Housman, D
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1999, 354 (1386) : 1029 - 1034
  • [39] Neurodegenerative processes in Huntington's disease
    Bano, D.
    Zanetti, F.
    Mende, Y.
    Nicotera, P.
    CELL DEATH & DISEASE, 2011, 2 : e228 - e228
  • [40] Neurodegenerative processes in Huntington's disease
    D Bano
    F Zanetti
    Y Mende
    P Nicotera
    Cell Death & Disease, 2011, 2 : e228 - e228